- Show
- All
- News
- Our research
- Articles
5th December 2019
Catching up on the state of publications at ISMPP West 2019
Oxford PharmaGenesis was delighted to attend the West Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 14 and 15 November 2019 in San Diego, CA, USA.
Continue reading4th December 2019
Practical considerations for Collaborative Research between the pharmaceutical industry and external investigators
Maureen Lloyd,1 Cynthia K Barbitsch,2 Mary Voehl Hirsch,3 Antonia Panayi,4 Eric Southam5
Continue reading2nd December 2019
Oxford PharmaGenesis Arrives in Cambridge
Continued growth has led Oxford PharmaGenesis, the leading HealthScience communications consultancy, to create a new UK office in Cambridge.
Continue reading26th November 2019
Oxford PharmaGenesis at World Orphan Drug Congress 2019
In mid-November Barcelona played host to the World Orphan Drug Congress 2019, Europe’s largest commercially focused conference for the rare disease community. Representatives from Oxford PharmaGenesis were in attendance over the 3-day meeting. The conference was broad-ranging in terms of sessions and speakers; however, there were some sessions of particular note.
Continue reading21st November 2019
Project Management Society's Patient Engagement Interest Group 2019: Patient Collaboration Uncut
Empowerment, not tokenism.
Earlier this month, members of the Oxford PharmaGenesis Patient Engagement Team attended the annual educational event hosted by the Project Management Society in London. The event was held at the British Academy on the Mall, and featured several speakers and an expert panel selected to explore what it means to co-create with the patient community.
Continue reading20th November 2019
Oxford PharmaGenesis Inc. celebrates its third consecutive year as a Great Place to Work®
Oxford PharmaGenesis Inc. has been named as a Great Place to Work® for the third consecutive year!
Continue reading